Kimmel Center for Biology and Medicine at the Skirball Institute, Department of Pathology, New York University School of Medicine, New York, NY, 10016, USA.
Proteomics Laboratory, Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, 10016, USA.
Nat Commun. 2017 Dec 20;8(1):2214. doi: 10.1038/s41467-017-02363-w.
Tankyrase 1 and 2 are poly(ADP-ribose) polymerases that function in pathways critical to cancer cell growth. Tankyrase-mediated PARylation marks protein targets for proteasomal degradation. Here, we generate human knockout cell lines to examine cell function and interrogate the proteome. We show that either tankyrase 1 or 2 is sufficient to maintain telomere length, but both are required to resolve telomere cohesion and maintain mitotic spindle integrity. Quantitative analysis of the proteome of tankyrase double knockout cells using isobaric tandem mass tags reveals targets of degradation, including antagonists of the Wnt/β-catenin signaling pathway (NKD1, NKD2, and HectD1) and three (Notch 1, 2, and 3) of the four Notch receptors. We show that tankyrases are required for Notch2 to exit the plasma membrane and enter the nucleus to activate transcription. Considering that Notch signaling is commonly activated in cancer, tankyrase inhibitors may have therapeutic potential in targeting this pathway.
端锚聚合酶 1 和 2 是多聚(ADP-核糖)聚合酶,在影响癌细胞生长的关键途径中发挥作用。端锚聚合酶介导的 PAR 化将蛋白靶标标记为蛋白酶体降解。在这里,我们生成了人类敲除细胞系,以检查细胞功能并探究蛋白质组。我们表明,端锚聚合酶 1 或 2 中的任何一种都足以维持端粒长度,但两者都需要解决端粒黏合并维持有丝分裂纺锤体的完整性。使用等重同位素标记相对和绝对定量串联质量标签对端锚聚合酶双敲除细胞的蛋白质组进行定量分析,揭示了降解的靶标,包括 Wnt/β-连环蛋白信号通路的拮抗剂(NKD1、NKD2 和 HectD1)以及四个 Notch 受体中的三个(Notch1、2 和 3)。我们表明,端锚聚合酶对于 Notch2 从质膜逸出并进入细胞核以激活转录是必需的。考虑到 Notch 信号通常在癌症中被激活,端锚聚合酶抑制剂可能具有针对该途径的治疗潜力。